Today
-0.80%
5 Days
-0.37%
1 Month
+2.62%
6 Months
+29.83%
Year to Date
+2.75%
1 Year
-3.88%
• Spotify shares declined due to lower earnings estimates and tech profit-taking. • Operating expenses and executive share sales contributed to persistent market volatility. • Annual revenue reached $20.44B, while analysts maintain an average price target of $608.92.
• Major brokerage firms recently reduced their price targets for AppLovin. • The stock exhibits neutral technical indicators alongside strong annual financial results. • Analysts maintain average price targets of $504.78 with varying forecasts.
• Oracle reported strong Q1 FY27 results driven by cloud infrastructure revenue growth. • Larry Ellison canceled his pre-arranged stock disposition plan without selling shares. • Analysts rate the company Buy with an average price target of $247.89.
• Snowflake reported strong quarterly performance and raised its full-year outlook. • Enterprise adoption of the AI Data Cloud platform accelerated consumption growth. • The company posted annual revenue of $4.68B and net loss of $1.33B.
• IBM faced profit-taking after finalizing a one billion dollar CHIPS Act award. • Delayed enterprise software upgrades and IT budget reallocations created short-term revenue headwinds. • Technical indicators show a MACD buy signal alongside neutral RSI and Williams readings.
• Oracle stock rebounded after five consecutive losses due to dip-buying. • Q1 cloud revenue growth and AI demand supported bullish investor sentiment. • High capital expenditure plans and leverage caused ongoing intraday market volatility.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.50% |
| BlackRock Institutional Trust Company, N.A. | 5.10% |
| State Street Investment Management (US) | 4.12% |
| Fidelity Management & Research Company LLC | 2.49% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 44.40% |
| Investment Advisor/Hedge Fund | 21.20% |
| Research Firm | 2.55% |
| Pension Fund | 2.38% |
Related Instruments